Catalyst Pharmaceutical Partners is Pharmaceuticals in United States that focus on Catalyst Pharmaceuticals Inc business. Founded in 2002. They cover business area such as Catalyst Pharmaceuticals Inc, innovative therapy, people, rare, debilitating, chronic neuromuscular and neurological disease, Firdapse, amifampridine phosphate, patient.
2002
( 24 years old in 2026 )
Catalyst Pharmaceuticals Inc
-
355 Alhambra Circle
Suite 801
Coral Gables, FL 33134
United States
Private
Catalyst Pharmaceuticals Incinnovative therapypeoplerare, debilitating, chronic neuromuscular and neurological diseaseFirdapseamifampridine phosphatepatient
* We use standard office opening hours in near Catalyst Pharmaceutical Partners's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Catalyst Pharmaceutical Partners is Pharmaceuticals business from United States that founded in 2002 (24 years old in 2026), Catalyst Pharmaceutical Partners business is focusing on Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceutical Partners headquarter office and corporate office address is located in 355 Alhambra Circle Suite 801 Coral Gables, FL 33134 United States.
Catalyst Pharmaceutical Partners was founded in United States.
In 2026, Catalyst Pharmaceutical Partners is currently focus on Catalyst Pharmaceuticals Inc sector.
Above is snippet of Google Trends for "Catalyst Pharmaceuticals Inc" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Catalyst Pharmaceutical Partners, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
